Legislative & Public Policy

We operate at the intersection of public policy and law, helping clients find solutions to complex problems that involve interacting with the federal government. We represent a cross-section of the world's most recognizable companies, associations, and organizations. We focus on healthcare/life sciences, financial services, energy, trade, technology, federal funding, foreign sovereign representation, and education. The issues we tackle require deft political handling as policy battles impact other areas, such as litigation, pending financial transactions, corporate risk management, business reputation, the media, and the consumer marketplace.

During the COVID-19 pandemic, we are working with clients to address unprecedented legislative and public policy challenges, including: (1) designation as essential industries; (2) maximizing access to capital lending facilities administered by the Treasury Department and the Federal Reserve; (3) aiding in eligibility for the SBA's Paycheck Protection Program; and (4) securing billions of dollars in direct and indirect aid for various industries such as hospitals, air freight cargo providers, and childcare providers.

Working with top-rated lawyers in a number of other practice groups at the firm, our team is able to help clients address multifaceted legal and policy problems from a variety of perspectives, leading to better and more comprehensive solutions.

With four of the youngest lobbyists on The Hill's recent top "Hired Guns" lists, we have our finger on the pulse of a rapidly evolving legislative environment that requires new strategies to succeed.

We are the largest law-firm based lobbying practice where a majority of lobbyists are women at a time when the number of women in Congress and in key decision making positions in Washington is at a record high.

» Visit Our Post-Election Analysis Center
White House in front of the US Capitol with stars of US flag in background

Experience Highlights

  • Advised life sciences companies and private equity investment firms concerning COVID-19 Congressional inquiries.
  • Advised and successfully advocated for the inclusion of $3 billion for aviation worker relief under the CARES Act on behalf of an airlines ground support services client.
  • Advocated for the creation of a multibillion stabilization fund to support the early care and learning industry affected by the COVID-19 national emergency.
  • Secured Medicare coverage for a client's breakthrough medical device through a coordinated congressional and agency effort.
  • Represented pharmaceutical manufacturers through congressional investigations and oversight hearings related to pricing, patents, and innovation in current and prior Congresses.
  • Advised multiple clients on legal and regulatory issues associated with Section 230 of the Communications Decency Act.
  • Represented a broad-based business coalition of 85 major trade and professional associations, following September 11 in fashioning and securing enactment of a federal terrorism insurance backstop to the Terrorism Risk Insurance Act of 2002 (TRIA) and in subsequent TRIA reauthorization campaigns; most recently the successful 2019 reauthorization.
  • Provided a large US distributor with comprehensive support for tariff exclusion requests, including developing more than 35 Section 301 exclusion requests, combined with congressional bipartisan, bicameral letters of support complimenting such requests.
  • Represented the world's largest electric vehicle charging network operator on policy issues impacting the deployment of alternative fuel vehicles, and led a coalition that successfully advocated for inclusion of a billion dollar multiyear grant program in House and Senate surface transportation legislation pending in the 116th Congress.
  • Secured language in the FY 2020 National Defense Authorization Act to increase funding for DOD 5G research and development programs by $270 million, including a specific directive to build a 5G R&D facility.
Subscribe
Subscribe Link

Email Disclaimer